Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:2938-2945
Published online before print October 25, 2004, doi: 10.1161/01.CIR.0000146891.31481.CF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/18/2938    most recent
01.CIR.0000146891.31481.CFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallbracht, K. B.
Right arrow Articles by Schultheiss, H.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallbracht, K. B.
Right arrow Articles by Schultheiss, H.-P.
Related Collections
Right arrow Other Vascular biology

(Circulation. 2004;110:2938-2945.)
© 2004 American Heart Association, Inc.


Vascular Medicine

Endothelium-Dependent Flow-Mediated Vasodilation of Systemic Arteries Is Impaired in Patients With Myocardial Virus Persistence

Katja B. Vallbracht, MD; Peter L. Schwimmbeck, MD; Uwe Kühl, MD, PhD; Bettina Seeberg, MD; Heinz-Peter Schultheiss, MD

From Charité Medical University, Berlin, Germany.

Correspondence to Dr Med Katja B. Vallbracht, Charité Medical University Berlin, Campus Benjamin Franklin, Department of Cardiology, Hindenburgdamm 30, 12200 Berlin, Germany. E-mail vallbrac{at}zedat.fu-berlin.de

Received October 31, 2003; de novo received January 31, 2004; revision received April 29, 2004; accepted April 30, 2004.

Background— Myocardial virus persistence is frequently observed in patients with cardiomyopathy. Endothelial dysfunction in patients with cardiomyopathy is associated with inflammatory immunoresponses in myocardial biopsies. The aim of this study was to investigate the impact of myocardial virus persistence on endothelial function.

Methods and Results— In 124 patients with suspected cardiomyopathy, myocardial biopsies were examined for virus persistence (by polymerase chain reaction) and inflammation (by immunohistology). Endothelial function of the radial artery was examined by high-resolution ultrasound. Diameter changes in response to reactive hyperemia (flow-mediated dilation [FMD]) compared with glycerol trinitrate (GTN-MD) were measured. Mean age of the patients (55 men, 69 women) was 45±13 years; ejection fraction was 57±17%. In 73 patients, adenovirus, enterovirus, parvovirus, or HHV6 virus (V) was detected; in 51, no virus was detected. FMD was significantly impaired in patients with myocardial virus persistence compared with control subjects (Co): FMD-V, 3.38±2.67%; FMD-Co, 7.34±3.44 (P<0.001). In 86 patients, myocardial inflammation was confirmed (Inf). Of those, 57 had virus, and 29 did not. FMD was significantly impaired in patients with virus compared with controls: FMD-Inf-V, 3.24±2.66%; FMD-Inf-Co, 6.07±3.00 (P<0.001). In 38 patients, immunohistology of the myocardial biopsies was normal (Co); of those, 16 had virus, and 22 did not. FMD was impaired in patients with virus compared with control subjects: FMD-Co-V, 3.88±2.72%; FMD-Co-Co, 9.00±3.32% (P<0.001). Endothelium-independent vasodilation (GTN-MD) was not significantly affected.

Conclusions— Myocardial virus persistence is associated with endothelial dysfunction. Endothelial dysfunction in patients with myocardial virus persistence can occur independently of endothelial activation or myocardial inflammation but is more pronounced in patients with concurrent inflammation.


Key Words: cardiomyopathy • endothelium • inflammation • viruses • vasodilation




This article has been cited by other articles:


Home page
HeartHome page
A Yilmaz, H Mahrholdt, A Athanasiadis, H Vogelsberg, G Meinhardt, M Voehringer, E-M Kispert, C Deluigi, H Baccouche, E Spodarev, et al.
Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis
Heart, November 1, 2008; 94(11): 1456 - 1463.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Yilmaz, K. Klingel, R. Kandolf, and U. Sechtem
A geographical mystery: do cardiotropic viruses respect national borders?
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 82 - 82.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Andreoletti
Reply.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 82 - 83.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. Andreoletti, L. Venteo, F. Douche-Aourik, F. Canas, G. L. de la Grandmaison, J. Jacques, H. Moret, N. Jovenin, J.-F. Mosnier, M. Matta, et al.
Active Coxsackieviral B Infection Is Associated With Disruption of Dystrophin in Endomyocardial Tissue of Patients Who Died Suddenly of Acute Myocardial Infarction
J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2207 - 2214.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. B. Vallbracht, P. L. Schwimmbeck, U. Kuhl, U. Rauch, B. Seeberg, and H.-P. Schultheiss
Differential Aspects of Endothelial Function of the Coronary Microcirculation Considering Myocardial Virus Persistence, Endothelial Activation, and Myocardial Leukocyte Infiltrates
Circulation, April 12, 2005; 111(14): 1784 - 1791.
[Abstract] [Full Text] [PDF]